NR1H4 and metabolic dysfunction-associated steatohepatitis: Furthermore, ginsenoside Rh4 alleviates hepatic steatosis, lobular inflammation, and bile acid dysregulation by modulating FXR signaling, while Rg5 exerts anti-NASH effects via the Notch1 pathway, which is critical for lipid metabolism and hepatocyte apoptosis prevention [78,79].